Literature DB >> 22659271

2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.

Grace J Noh1, John M Graham.   

Abstract

We report a 2-year-old female who initially presented with seizures, developmental delay and dysmorphic features and was found to have a 0.3 Mb deletion at chromosome 2q23.1 encompassing the critical seizure gene, MBD5. Her distinct physical features include bifrontal narrowing with brachycephaly, low anterior hairline, hypotonic facial features with short upturned nose, flat nasal bridge, hypertelorism, tented upper lip with everted lower lip, downturned corners of her mouth, and relatively coarse facial features including thickened tongue. She also had a short neck, brachytelephalangy, clinodactyly, and hypertrichosis. At 3½ years she developed progressive ataxia and lost vocabulary at the age of 4. Regression has been reported in one other case of MBD5 deletion. MBD5 is a member of the methyl binding gene family and appears to be responsible for regulating DNA methylation in the central nervous system. Our patient was entirely deleted for the MBD5 gene with partial loss of the EPC2 gene, which suggests that haploinsufficiency of MBD5 is responsible for the distinct phenotype observed. This supports the hypothesis that MBD5 is indeed the critical gene implicated for the findings seen in patients with deletions of chromosome 2q23.1. Further studies are necessary to delineate the role that the MBD5 gene plays in the development of the brain and these specific physical characteristics.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659271     DOI: 10.1016/j.ejmg.2012.05.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  Extended spectrum of MBD5 mutations in neurodevelopmental disorders.

Authors:  Céline Bonnet; Asma Ali Khan; Emmanuel Bresso; Charlène Vigouroux; Mylène Béri; Sarah Lejczak; Bénédicte Deemer; Joris Andrieux; Christophe Philippe; Anne Moncla; Irina Giurgea; Marie-Dominique Devignes; Bruno Leheup; Philippe Jonveaux
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

Review 2.  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

Authors:  Sureni V Mullegama; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

3.  Next Generation Sequencing of 134 Children with Autism Spectrum Disorder and Regression.

Authors:  Jiani Yin; Chun-An Chun; Nikolay N Zavadenko; Natalia L Pechatnikova; Oxana Yu Naumova; Harsha V Doddapaneni; Jianhong Hu; Donna M Muzny; Christian P Schaaf; Elena L Grigorenko
Journal:  Genes (Basel)       Date:  2020-07-25       Impact factor: 4.096

4.  Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome.

Authors:  Vladimir Camarena; Lei Cao; Clemer Abad; Alexander Abrams; Yaima Toledo; Kimi Araki; Masatake Araki; Katherina Walz; Juan I Young
Journal:  EMBO Mol Med       Date:  2014-08       Impact factor: 12.137

5.  The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome.

Authors:  Katherina Walz; Juan I Young
Journal:  Rare Dis       Date:  2014-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.